Comprehensive detection of diverse exon 19 deletion mutations of EGFR in lung Cancer by a single probe set

Biosens Bioelectron. 2015 Dec 15:74:849-55. doi: 10.1016/j.bios.2015.07.043. Epub 2015 Jul 21.

Abstract

Detection of exon 19 deletion mutation of EGFR, one of the most frequently occurring mutations in lung cancer, provides the crucial information for diagnosis and treatment guideline in non-small-cell lung cancer (NSCLC). Here, we demonstrate a simple and efficient method to detect various exon 19 deletion mutations of EGFR using a single probe set comprising of an oligo-quencher (oligo-Q) and a molecular beacon (MB). While the MB hybridizes to both the wild and mutant target DNA, the oligo-Q only binds to the wild target DNA, leading to a fluorescent signal in case of deletion mutation. This enables the comprehensive detection of the diverse exon 19 deletion mutations using a single probe set. We demonstrated the utility and efficiency of the approach by detecting the frequent exon 19 deletion mutations of EGFR through a real-time PCR and in situ fluorescence imaging. Our approach enabled the detection of genomic DNA as low as 0.02 ng, showing a detection limit of 2% in a heterogeneous DNA mixture, and could be used for detecting mutations in a single cell level. The present MB and oligo-Q dual probe system can be used for diagnosis and treatment guideline in NSCLC.

Keywords: EGFR; Exon 19 deletion mutations; Lung cancer; Molecular beacon; Oligo-quencher.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biosensing Techniques*
  • Carcinoma, Non-Small-Cell Lung / diagnosis*
  • Carcinoma, Non-Small-Cell Lung / genetics
  • DNA, Neoplasm / genetics
  • DNA, Neoplasm / isolation & purification*
  • ErbB Receptors / genetics
  • ErbB Receptors / isolation & purification*
  • Exons
  • Humans
  • Mutation
  • Sequence Deletion

Substances

  • DNA, Neoplasm
  • EGFR protein, human
  • ErbB Receptors